Schedule 13G ownership disclosure

Orexigen Therapeutics, Inc.

Security class unavailable · CUSIP: 686164104

Event date: 2015-07-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,229,287
Percent of class
0.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-046001
Form type
SC 13G
Filer
Foresite Capital Fund III, L.P.
CIK
CIK 1645158
Filed
Aug 04, 2015
Reporting period
Jul 23, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub